Inactive Instrument

Press Releases CELLCEUTIX OTC Bulletin Board

Equities

CTIX

US15115V1017

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Feb. 01	Innovation Pharmaceuticals Inc. Announces Resignation of Board Members	CI
2023	Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement	CI

Press Releases

Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024	23-08-28	AQ
Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases	23-06-21	AQ
Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing	23-06-05	AQ
Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications	23-04-17	AQ
Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers	23-03-15	AQ
Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission	23-02-23	AQ
INNOVATION PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	23-02-15	AQ
Innovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement	23-01-09	AQ
INNOVATION PHARMACEUTICALS INC. : Other Events (form 8-K)	23-01-04	AQ
Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin's Potential for Treating Fungal Keratitis	22-12-14	AQ
Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin’s Potential for Treating Fungal Keratitis	22-12-13	AQ
Innovation Pharmaceuticals Announces BT BeaMedical Technologies Receives FDA Clearance for New Surgical Laser Family	22-11-28	AQ
Scientific Poster on Innovation Pharmaceuticals Brilacidin to be Presented at 2022 Chemical and Biological Defense Science & Technology Conference	22-11-16	AQ
INNOVATION PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-10	AQ
Innovation Pharmaceuticals - NHS Medical Director for Specialised Services Calls New Laser Technology for Epilepsy 'Game-Changing Breakthrough'	22-10-27	AQ
NHS Medical Director for Specialised Services Calls New Laser Technology for Epilepsy "Game-Changing Breakthrough"	22-10-26	AQ
Innovation Pharmaceuticals Announces Publication of Scientific Article on the Antifungal Activity of Brilacidin	22-10-04	AQ
INNOVATION PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-09-28	AQ
New In Vitro Data Supporting the Broad-Spectrum Antiviral Activity of Innovation Pharmaceuticals Brilacidin Presented at 2022 Military Health System Research Symposium	22-09-16	AQ
Innovation Pharmaceuticals Investment in BT BeaMedical Helping Advance New Surgical Laser Platform	22-09-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases CELLCEUTIX OTC Bulletin Board

Equities

CTIX

US15115V1017

Press Releases

Filters